Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metvix PDT vs Cryotherapy in Superficial Basal Cell Carcinoma
NCT00469417Phase 3Completed
- Sponsor
- Galderma
- Start
- Oct 1999
- Primary completion
- Sep 2001
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 7
01
Overview
A Phase 3 trial of methyl aminolevulinate in basal cell carcinoma (BCC), sponsored by Galderma. Started Oct 1999; status: completed.
02
Drugs
methyl aminolevulinate
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT00469417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00469417.